A study led by clinician-scientists and scientists from the National Cancer Centre Singapore (NCCS) and A*STAR’s Genome Institute of Singapore (GIS) and funded by the National Research Foundation Singapore (NRF) has discovered unexpected molecular heterogeneity even within the same liver tumors. More than 40% of HCC harbors more than one molecular subtype within the same tumor and in these, the clinical outcomes for the patients are best predicted by the most aggressive subtype.
Virginia Tech student receives NSF support to pursue new line of research into the health impact of ultra-processed foods
Zach Hutelin, a doctoral candidate in the Virginia Tech’s Translational Biology, Medicine, and Health (TBMH) Graduate Program, has been awarded a prestigious National Science Foundation